Evonik announced today that it signed an agreement for medical technology company Coopmed to distribute the epicite wound dressing.
Jena, Germany-based Evonik said Coopmed will distribute the epicite dressing made from biosynthetic cellulose exclusively to the German market for chronic wound care. Epicite represents part of the portfolio from JeNaCell, which Evonik acquired in 2021.
“We are excited to work with a highly experienced partner like Coopmed for the market development and distribution of epicite® to advance the treatment of chronic wounds,” said Dana Kralisch, GM of JeNaCell. “Together, we will work to make epicite® available to outpatients throughout Germany. We would like to thank all wound experts and professional users who supported us with case studies, practical advice and their personal experiences using the product.”
JeNaCell is designed to produce biosynthetic cellulose. The nature-identical material is suitable for wound cleansing an…